Skip to main content

Table 1 Characteristics of 21 patients with carbapenemase-producing P. aeruginosa

From: Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany

Patient characteristics (n = 21)

Value

Age (years)

 mean

62

 range

20; 80

Sex

 male

16 (76.2%)

Source of first positive specimen

 respiratory tract

7 (33.3%)

 urine

5 (23.8%)

 screening (rectum)

5 (23.8%)

 wound

2 (9.5%)

 other

2 (9.5%)

Infection/colonization with CPPA

 hospital-acquired

15 (71.4%)

 community-acquired

6 (28.6%)

Day of acquisition during hospital stay (hospital-acquired CPPA only; n = 15)

 mean

19

 range

8; 82

Medical centres

 tertiary care

20 (95.2%)

 secondary care

1 (4.8%)

 children hospital

0 (0%)

Ward type

 ICU

14 (66.7%)

 general ward

7 (33.3%)

Medical departments

 surgery

11 (52.4%)

 internal medicine

8 (38.1%)

 others

2 (9.5%)

Hospital-acquired infection (CDC)

 pneumonia

5 (23.8%)

 urinary tract

2 (9.5%)

 skin infection

2 (9.5%)

Antipseudomonal antibiotic therapya

15 (71.4%)

Surgerya

15 (71.4%)

Nonsurgical interventiona

19 (90.5%)

Dialysisa

6 (28.6%)

Mechanical ventilationa

16 (76.2%)

Woundsa

15 (71.4%)

Central linea

17 (80.1%)

Urinary cathetera

18 (85.7%)

  1. awithin a maximal interval of 7 days before first isolation of CPPA